IPO lockup expirations: Livongo Health (NASDAQ:LVGO) Health Catalyst (NASDAQ:HCAT), Castle Biosciences (NASDAQ:CSTL) all see their share lockups expire on January 21.
Companies forecast to make a quarterly payout change include Allergan (NYSE:AGN) to $0.76 from $0.74, Healthcare Services (NASDAQ:HCSG) to $0.2013 from $0.20.
FDA watch: The action date for Epizyme’s (NASDAQ:EPZM) tazemetostat for epitheloid sarcoma arrives next week. Merck (NYSE:MRK) also has a PDUFA date coming up on DIFICID. Meanwhile, Forty Seven (NASDAQ:FTSV) and Bellicum Pharmaceuticals (NASDAQ:BLCM) are both expected to present Phase 1 results at the ASCO GI Cancers Symposium running from January 23-25 in San Francisco.
Short report: The list of stocks heading into the trading week with an elevated level of short interest as a percentage of total float includes Health Insurance Innovations (NASDAQ:HIIQ), Mallinckrodt (NYSE:MNK), Accelerate Diagnostics (NASDAQ:AXDX), Akcea Therapeutics (NASDAQ:AKCA), Intrexon Corp (NASDAQ:XON), AMAG Pharmaceuticals (NASDAQ:AMAG), Lannett Company (NYSE:LCI), Clovis Oncology (NASDAQ:CLVS), OptiNose (NASDAQ:OPTN) and Ligand Pharmaceuticals (NASDAQ:LGND).
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.